Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05878119 · ClinicalTrials.gov registry record · Phase 2

Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program

A Phase 2 study of Healthy, sponsored by Metro International Biotech.

Completed
Registry status
Phase 2
Development phase
124
Enrollment target
1
Study location

NCT05878119 is a Phase 2 study of Healthy that has completed, run by Metro International Biotech. The registered enrollment target is 124 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05878119, a Phase 2 study of Healthy, has completed, sponsored by Metro International Biotech.

COMPLETED
Registry status
Phase 2
Development phase
124 participants
Enrollment target
1
Study location

Study Summary

A single-center, randomized, placebo-controlled study in community dwelling, healthy, regularly exercising, highly physically fit men and women, 19 to 40 years. Eligible participants will be randomized to receive either 1000 mg NMN or placebo twice daily for 10 weeks.

Conditions Studied

Healthy

Interventions

  • DRUG Placebo
  • DRUG Investigational Product - MIB 626
  • OTHER Standardized, progressive, high intensity, multidimensional exercise
  • OTHER Usual Physical Activity

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2023-10-25
Est. Completion 2025-08-04
Phase Phase 2

Sponsor

Metro International Biotech

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05878119

The ClinicalTrials.gov registry entry for NCT05878119 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The listed sponsor is Metro International Biotech, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT05878119 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05878119 about?

NCT05878119 is a clinical study titled "Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program". A single-center, randomized, placebo-controlled study in community dwelling, healthy, regularly exercising, highly physically fit men and women, 19 to 40 years. Eligible participants will be randomized to receive either 1000 mg NMN or placebo twice daily for 10 weeks.

What is the current status of trial NCT05878119?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 124 participants. The study started on 2023-10-25. Estimated completion is 2025-08-04.

What conditions does trial NCT05878119 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT05878119?

The interventions under investigation include: Placebo (DRUG), Investigational Product - MIB 626 (DRUG), Standardized, progressive, high intensity, multidimensional exercise (OTHER), Usual Physical Activity (OTHER).

Who is sponsoring clinical trial NCT05878119?

This trial is sponsored by Metro International Biotech, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05878119 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.